Поисковый запрос: (<.>A=Xiang, Rong$<.>) |
Общее количество найденных документов : 32
Показаны документы с 1 по 20
|
|
1.
| A preclinical evaluation of a novel multikinase inhibitor, SKLB-329, as a therapeutic agent against hepatocellular carcinoma // Int. J. Cancer, 2014. Vol. 135, N 12.-С.2972-2983
|
2.
| A preclinical evaluation of a novel multikinase inhibitor, SKLB-329, as a therapeutic agent against hepatocellular carcinoma // Int. J. Cancer, 2014. Vol. 135, N 12.-С.2972-2983
|
3.
| Chen RTN3 and RTN4: Candidate modulators in vascular cell apoptosis and atherosclerosis // J. Cell. Biochem., 2010. Vol. 111, N 4.-С.797-800
|
4.
| DNA vaccines suppress tumor growth and metastases by the induction of anti-angiogenesis // Immunol. Rev., 2004. Vol. 199, N 1.-С.181-190
|
5.
| Induction of persistent tumor-protective immunity in mice cured of established colon carcinoma metastases // Cancer Res., 1998. Vol. 58, N 17.-С.3918-3925
|
6.
| Induction of persistent tumor-protective immunity in mice cured of established colon carcinoma metastases // Cancer Res., 1998. Vol. 58, N 17.-С.3918-3925
|
7.
| Induction of persistent tumor-protective immunity in mice cured of established colon carcinoma metastases // Cancer Res., 1998. Vol. 58, N 17.-С.3918-3925
|
8.
| Inhibition of tumor growth by U0126 is associated with induction of interferon-'гамма' production // Int. J. Cancer, 2015. Vol. 136, N 4.-С.771-783
|
9.
| Inhibition of tumor growth by U0126 is associated with induction of interferon-'гамма' production // Int. J. Cancer, 2015. Vol. 136, N 4.-С.771-783
|
10.
| Legumain: A biomarker for diagnosis and prognosis of human ovarian cancer // J. Cell. Biochem., 2012. Vol. 113, N 8.-С.2679-2686
|
11.
| Legumain: A biomarker for diagnosis and prognosis of human ovarian cancer // J. Cell. Biochem., 2012. Vol. 113, N 8.-С.2679-2686
|
12.
| Legumain: A biomarker for diagnosis and prognosis of human ovarian cancer // J. Cell. Biochem., 2012. Vol. 113, N 8.-С.2679-2686
|
13.
| Legumain: A biomarker for diagnosis and prognosis of human ovarian cancer // J. Cell. Biochem., 2012. Vol. 113, N 8.-С.2679-2686
|
14.
| Natural killer cell-mediated eradication of neuroblastoma metastases to bone marrow by targeted interleukin-2 therapy // Blood, 1998. Vol. 91, N 5.-С.1706-1715
|
15.
| Natural killer cell-mediated eradication of neuroblastoma metastases to bone marrow by targeted interleukin-2 therapy // Blood, 1998. Vol. 91, N 5.-С.1706-1715
|
16.
| Natural killer cell-mediated eradication of neuroblastoma metastases to bone marrow by targeted interleukin-2 therapy // Blood, 1998. Vol. 91, N 5.-С.1706-1715
|
17.
| Overexpression of Oct4 suppresses the metastatic potential of breast cancer cells via Rnd1 downregulation // Biochim. et biophys. acta. Mol. Basis Disease, 2014. Vol. 1842, N 11.-С.2087-2095
|
18.
| Shift from systemic to site-specific memory by tumor-targeted IL-2 // J. Immunol., 2004. Vol. 172, N 10.-С.5843-5850
|
19.
| Shift from systemic to site-specific memory by tumor-targeted IL-2 // J. Immunol., 2004. Vol. 172, N 10.-С.5843-5850
|
20.
| Synergy between an antiangiogenic integrin 'альфа'[v] antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases // Proc. Nat. Acad. Sci. USA, 1999. Vol. 96, N 4.-С.1591-1596
|
&uf('+1W2226#',v2226), ?>
|
|